Monoprost (Latanoprost)

Latanoprost activates prostaglandin F receptors in the eye, which remodels the extracellular matrix of the ciliary body and increases uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure.

The dosing regimen for Monoprost is determined by the prescribing ophthalmologist. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but the exact dose and schedule must follow the prescriber’s instructions.

The safety of latanoprost in pregnancy or lactation has not been definitively established. Healthcare providers should weigh potential benefits against risks and consider alternative treatments if pregnancy or breastfeeding is planned or ongoing.

To order Monoprost, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more convenient dosing schedule but may cause distinct ocular side effects such as iris darkening.

Monoprost eye drops should be stored at room temperature, protected from light and moisture. Keep the bottle tightly closed, store in the original packaging, and avoid freezing. Discard any solution that appears discolored or contains particles.

Monoprost is applied as a single drop to the conjunctival sac of the affected eye(s) once daily, usually in the evening. The patient should tilt the head back, pull down the lower eyelid, instill the drop, and close the eye gently without rubbing.

Serious risks include severe allergic reactions, uveitis, corneal edema, paradoxical rise in intra‑ocular pressure, and vision loss. Patients should seek immediate medical attention if they experience intense eye pain, sudden vision changes, or signs of an allergic response.

Monoprost should be avoided in patients with active ocular infections, severe inflammation, known hypersensitivity to latanoprost or any component of the formulation, and in individuals where the prescriber determines the risks outweigh the benefits.